Ashish Kacholia Portfolio Shares: Renowned investor Ashish Kacholia has bought additional 0.5 per cent stakes in this multibagger stock – Xpro India during September 2022 quarter as per the shareholding pattern. The packaging company shares hit an upper circuit of 5 per cent to Rs 729 apiece on the exchanges on Monday.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

Ashish Kacholia now has 4.4 per cent stakes (7,79,350 shares) in Xpro India as per the September shareholding pattern as against 3.9 per cent stakes during June quarter, the stock analysis website trendlyne.com showed.

The ace investor Kacholia made a fresh in entry stock by picking around 2.5 per cent stakes in Xpro India in September 2021 quarter and has been gradually increasing its holding almost every quarter since last year.

Kacholia’s Net Worth

Ashish Kacholia, who is fondly known as Big Whale of the Indian stock market, publicly holds 38 stocks with a net worth of over Rs 1,776.6 crore as of October 17, 2022, according to trendlyne.com. He has a varied portfolio that includes hospitality, education, infra and manufacturing stocks.

About Xpro India

Established in 1998, Xpro India is a diversified multi-divisional, multi-locational company with a strong commitment to the polymer processing industry. The company has manufacturing units at various places in India namely West Bengal, Uttar Pradesh, and Maharashtra.

Xpro India is into the manufacturing of products such as BOPP Films, Coex Cast Films, Coex Sheets, Dielectric Films, and Thermoformed Liners among others.

Share Price History

Xpro India shares in the last two years have given multi-fold (5300 per cent) returns from the Rs 13.5 level on October 16, 2020, to the Rs 729 level of today’s closing. The stock has gained over 63 per cent in the last one year & 16 per cent year-to-date.

Portfolio Rejig

So far in the September quarter, the investor has stayed put in Inflame Appliances and Ami Organics with 4.2 and 2.1 per cent stakes respectively and has slashed stakes in VRL Logistics and Beta Drugs below 1 per cent holding, as per trendlyne.com.